IL-17A producing lymphocytes in end stage lung disease
M. Albrecht (Hannover, Germany), D. Ishola Olawaseun (Hannover, Germany), S. Pallenberg (Hannover, Germany), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), G. Warnecke (Hannover, Germany), G. Hansen (Hannover, Germany), A. Dittrich (Hannover, Germany)
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Albrecht (Hannover, Germany), D. Ishola Olawaseun (Hannover, Germany), S. Pallenberg (Hannover, Germany), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), G. Warnecke (Hannover, Germany), G. Hansen (Hannover, Germany), A. Dittrich (Hannover, Germany). IL-17A producing lymphocytes in end stage lung disease. 1119
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: